Neuro-Bio’s CEO, Susan Greenfield, has been invited in Vienna for the 8th EAN Congress, which is the forum for general neurology in Europe with all specialties of its field being represented with around 6000 participants. While clinical developments play an important role in their programme, a strong focus is also on ground-breaking research with a translational aspect which fits ideally with Neuro-Bio’s scientific achievements and merits.
The first session will take place on Saturday, 25 June 2022 from 18:30 to 20:00 where Susan Greenfield will give the opening lecture for the meeting, titled: “From idea to reality: developing a new treatment for Alzheimer’s.”
The second session will be held on Sunday, 26 June 2022 from 13:00 to 14:30 where Susan Greenfield has been invited as a speaker for a Networking Event on “Challenges for women in neurology”. The aim of this event is to help identify and overcome the challenges that women may find during their academic and hospital career development in neurology. This event is mainly directed to female neurology residents and female neurologists at the beginning of their career.
Neuro-Bio is delighted to have been given this unique opportunity.